Thomas Lategan
Consigliere Generale presso BRIGHT MINDS BIOSCIENCES INC.
Profilo
Thomas Lategan is currently the Vice President of Regulatory Affairs at Bright Minds Biosciences, Inc. He previously held the same position at The Medicines Co., Actelion Pharmaceuticals US, Inc., Panacos Pharmaceuticals, Inc., and NeurAxon, Inc. He also worked as a Principal at Roche Corp.
Lategan holds a doctorate degree from the University of Oxford and an undergraduate degree from the University of Aberdeen.
Posizioni attive di Thomas Lategan
| Società | Posizione | Inizio |
|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Consigliere Generale | 14/06/2021 |
Precedenti posizioni note di Thomas Lategan
| Società | Posizione | Fine |
|---|---|---|
NeurAxon, Inc.
 NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | Consigliere Generale | 01/11/2015 |
| PANACOS PHARMACEUTICALS, INC. | Consigliere Generale | 01/09/2008 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Consigliere Generale | 01/02/2007 |
| THE MEDICINES COMPANY | Consigliere Generale | 01/02/2000 |
| Roche Corp. | Corporate Officer/Principal | - |
Formazione di Thomas Lategan
| University of Oxford | Doctorate Degree |
| University of Aberdeen | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | Commercial Services |
| Roche Corp. |
- Borsa valori
- Insiders
- Thomas Lategan
